Related references
Note: Only part of the references are listed.Institution-Wide QT Alert System Identifies Patients With a High Risk of Mortality
Kristina H. Haugaa et al.
MAYO CLINIC PROCEEDINGS (2013)
Drug-induced immune thrombocytopaenia: results from the Berlin Case-Control Surveillance Study
Edeltraut Garbe et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Severe sustained cholestatic hepatitis following temozolomide in a patient with glioblastoma multiforme: case study and review of data from the FDA adverse event reporting system
Giselle Sarganas et al.
NEURO-ONCOLOGY (2012)
Drug induced immune haemolytic anaemia in the Berlin Case-Control Surveillance Study
Edeltraut Garbe et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines?
H. G. Laverty et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
54-year-old male with hepatic cirrhosis and therapy-associated torsade de pointes tachycardia
M. Lehmann et al.
INTERNIST (2011)
Antimicrobials and the Risk of Torsades de Pointes The Contribution from Data Mining of the US FDA Adverse Event Reporting System
Elisabetta Poluzzi et al.
DRUG SAFETY (2010)
Drug-Induced Long QT Syndrome
Prince Kannankeril et al.
PHARMACOLOGICAL REVIEWS (2010)
QT Alterations in Psychopharmacology: Proven Candidates and Suspects
Paulino Antonio Alvarez et al.
CURRENT DRUG SAFETY (2010)
Proarrhythmic Risk with Antipsychotic and Antidepressant Drugs Implications in the Elderly
W. Victor R. Vieweg et al.
DRUGS & AGING (2009)
Psychotropic Drugs Associated With Corrected QT Interval Prolongation
Charlotte van Noord et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2009)
Drug-induced torsades de pointes: data mining of the public version of the FDA Adverse Event Reporting System (AERS)
Elisabetta Poluzzi et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2009)
Case ascertainment and estimated incidence of drug-induced long-QT syndrome: study in Southwest France
Mariam Molokhia et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Cellular basis of drug-induced torsades de pointes
D. M. Roden
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Terlipressin-induced ventricular arrhythmia
Jan Urge et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2008)
Risk factors and predictors of Torsade de Pointes ventricular tachycardia in patients with left ventricular Systolic dysfunction receiving Dofetilide
Henriette Sloth Pedersen et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Increased QT interval variability index in acute alcohol withdrawal
Karl-Juergen Baer et al.
DRUG AND ALCOHOL DEPENDENCE (2007)
Can pharmacogenetics help rescue drugs withdrawn from the market?
Rashmi R. Shah
PHARMACOGENOMICS (2006)
Inaccurate electrocardiographic interpretation of long QT:: The majority of physicians cannot recognize a long QT when they see one
S Viskin et al.
HEART RHYTHM (2005)
Sex differences in ventricular repolarization: from cardiac electrophysiology to Torsades de Pointes
N Abi-Gerges et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2004)
Drug therapy: Drug-induced prolongation of the QT interval
DM Roden
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development
WS Redfern et al.
CARDIOVASCULAR RESEARCH (2003)
Physician-induced torsade de pointes - Therapeutic implications
W Haverkamp et al.
CARDIOVASCULAR DRUGS AND THERAPY (2002)
Share Paper
